Sue Arata Posted May 24, 2019 Share Posted May 24, 2019 Hello, We are seeing an increase of patients on the new oncology drug for multiple myeloma (DARALEX/DARATUMUMAB) and I was wondering if anyone had any useful tips to share. Currently our procedure states to do a baseline ABSC prior to initiating the drug and to antigen type for at least Kell. Additionally, if the ABSC is positive in Gel, to rerun it in tube and to do an immediate spin crossmatch on Kell negative units (provided of course that the patient is Kell negative). Just wondering if this is how other places are handling these patients. Thanks, Sue Arata Link to comment Share on other sites More sharing options...
Malcolm Needs ★ Posted May 24, 2019 Share Posted May 24, 2019 If your patient is Kell Negative (Ko) you have real problems. If your patient is K Negative, you, and your patient, have more chance! TreeMoss, Townsend and BloodBankBlake 1 2 Link to comment Share on other sites More sharing options...
Neil Blumberg Posted May 27, 2019 Share Posted May 27, 2019 (edited) If you have access to a maternity service, cord cells are negative for CD38, thus we use a homemade cord cell panel, which has been inexpensive and 100% successful in screening for clinically significant anti-red cell antibodies. This drug is going to be used more frequently in initial treatment for multiple myeloma so one might as well be prepared for doing this very frequently in the future. Fortunately these patients are not heavily transfused and only occasionally have alloantibodies. Transfusion. 2015 Sep;55(9):2292-3. doi: 10.1111/trf.13174. Alternatively, you can use DTT, see the above letter for references. Daratumumab cord cell method.pdf Edited May 27, 2019 by Neil Blumberg Added attachment Sue Arata 1 Link to comment Share on other sites More sharing options...
carolyn swickard Posted May 27, 2019 Share Posted May 27, 2019 You should probably get used to the DTT procedure. Hemo-BioScience offers the reagent in small aliquots that can be used easily without bothering with trying to manufacture the stuff. There are several threads on this already on this site. Do a search and see the discussions. I had posted our procedure in one - let me know if it is not accessible now and I can send it to you. The cord panel method would be nice if you are doing a lot of pts, and at least the cells will last a while. DDT treated cells will not last long at all. noelrbrown and Sue Arata 2 Link to comment Share on other sites More sharing options...
Malcolm Needs ★ Posted May 27, 2019 Share Posted May 27, 2019 55 minutes ago, cswickard said: DDT treated cells will not last long at all. If you use DDT, you won't last long either!!!!!!!!!! SORRY, I couldn't resist it!!!!!!!!!! TreeMoss, Arno, Ensis01 and 3 others 2 4 Link to comment Share on other sites More sharing options...
Malcolm Needs ★ Posted May 27, 2019 Share Posted May 27, 2019 2 hours ago, Neil Blumberg said: If you have access to a maternity service, cord cells are negative for CD38, thus we use a homemade cord cell panel, which has been inexpensive and 100% successful in screening for clinically significant anti-red cell antibodies. This drug is going to be used more frequently in initial treatment for multiple myeloma so one might as well be prepared for doing this very frequently in the future. Fortunately these patients are not heavily transfused and only occasionally have alloantibodies. Transfusion. 2015 Sep;55(9):2292-3. doi: 10.1111/trf.13174. Alternatively, you can use DTT, see the above letter for references. Daratumumab cord cell method.pdf 46.52 kB · 2 downloads Great Idea Neil, but again, this side of the pond, using cord blood for screening is a problem, because we have a law about using any body parts (including blood cells) without specific written permission from, in this case, the mother, following a court case when a hospital in Birmingham kept body parts from paediatric patients without parental permission (indeed, without telling them at all). This has really made things VERY difficult for us. These only (easily) leaves the option of DTT-treated red cells. Link to comment Share on other sites More sharing options...
carolyn swickard Posted May 27, 2019 Share Posted May 27, 2019 sorry - fighting a cold - at least I got it right once!!!! Malcolm Needs 1 Link to comment Share on other sites More sharing options...
Patty Posted May 28, 2019 Share Posted May 28, 2019 You could antigen type the patient pre-Darzalex and transfuse phenotypically similar blood with a deviation form signed. Or DDT treat and give least Incompatible K neg blood. DDT destroys K. Link to comment Share on other sites More sharing options...
Malcolm Needs ★ Posted May 28, 2019 Share Posted May 28, 2019 40 minutes ago, Patty said: You could antigen type the patient pre-Darzalex and transfuse phenotypically similar blood with a deviation form signed. Or DDT treat and give least Incompatible K neg blood. DDT destroys K. I think you will find that dichloro-diphenyl-trichloroethane will destroy a lot more than just the Kell Blood Group System antigens!!!!!!!!!!! BloodBankBlake, noelrbrown and MAGNUM 2 1 Link to comment Share on other sites More sharing options...
Arno Posted May 28, 2019 Share Posted May 28, 2019 https://www.ncbi.nlm.nih.gov/pubmed/30779172 Interesting method developed in Brazil if you get access to the drug. Link to comment Share on other sites More sharing options...
TreeMoss Posted May 28, 2019 Share Posted May 28, 2019 We will do a pre-darzelex blood type and antibody screen as well as antigen-type the patient for all antigens that we have anti-sera for. When transfusion is needed after the darzelex is started, we will use phenotypically-matched packed cells. If the patient specimens don't come until after the patient has received the drug, we send the specimens to our Red Cross Reference Lab buddies to work up for us. They use the DTT (not DDT!) and antigen-type the patient to provide information for our future use. Townsend and Malcolm Needs 1 1 Link to comment Share on other sites More sharing options...
tkakin Posted May 29, 2019 Share Posted May 29, 2019 We are not phenotypically matching units unless the DTT treatment does not work or they have developed an antibody. Ensis01 1 Link to comment Share on other sites More sharing options...
Cliff Posted June 1, 2019 Share Posted June 1, 2019 On 5/24/2019 at 3:08 PM, Malcolm Needs said: If your patient is Kell Negative (Ko) you have real problems. If your patient is K Negative, you, and your patient, have more chance! On 5/27/2019 at 1:16 PM, Malcolm Needs said: If you use DDT, you won't last long either!!!!!!!!!! SORRY, I couldn't resist it!!!!!!!!!! On 5/28/2019 at 6:54 AM, Malcolm Needs said: I think you will find that dichloro-diphenyl-trichloroethane will destroy a lot more than just the Kell Blood Group System antigens!!!!!!!!!!! Link to comment Share on other sites More sharing options...
Mabel Adams Posted June 3, 2019 Share Posted June 3, 2019 We are doing pre-treatment antibody screens and sending out for full molecular typing. We started this before we were doing DTT treatment in house. We serologically K type them if we need to give blood before the molecular typing results are back. Now I am not so sure that the full typing is justified. It seems to us that those who need transfusion whilst on the drug often don't stay on the drug long-term. As mentioned above the majority of patients on it don't require transfusion. I'm not going to change policies right away but am interested in others' experience. Link to comment Share on other sites More sharing options...
labguru Posted April 3, 2020 Share Posted April 3, 2020 On 5/28/2019 at 6:13 AM, Patty said: You could antigen type the patient pre-Darzalex and transfuse phenotypically similar blood with a deviation form signed. Or DDT treat and give least Incompatible K neg blood. DDT destroys K. Do you need to send notification to the FDA on these since the crossmatch will be positive? Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now